Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02088034 · ClinicalTrials.gov registry record · Phase 4
Intervention to Promote Weight Loss in Latinas At-risk for Diabetes
A Phase 4 study of Diabetes, sponsored by Temple University.
- Completed
- Registry status
- Phase 4
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT02088034: Completed Phase 4 study of Diabetes, sponsored by Temple University.
NCT02088034 is a Phase 4 study of Diabetes that has completed, run by Temple University. The registered enrollment target is 92 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02088034, a Phase 4 study of Diabetes, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of this project is to develop and test a behavioral intervention delivered by promotoras to help at-risk Latinas lose weight and prevent diabetes.
Primary Outcome
Study tests difference in body weight (Weight in kg) between treatment conditions and usual care at 12 months.
Conditions Studied
Interventions
- OTHER Usual Care
- BEHAVIORAL Promotora-led Intervention
- DRUG Metformin Therapy
Study Locations (1)
Pennsylvania
- Temple University - Center for Obesity Research and Education - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-02 |
| Phase | Phase 4 |
What the finished NCT02088034 record still lists
NCT02088034 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.
NCT02088034 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02088034 about?
NCT02088034 is a clinical study titled "Intervention to Promote Weight Loss in Latinas At-risk for Diabetes". The overarching goal of this project is to develop and test a behavioral intervention delivered by promotoras to help at-risk Latinas lose weight and prevent diabetes.
What is the current status of trial NCT02088034?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 92 participants. The study started on 2013-09. Estimated completion is 2016-02.
What conditions does trial NCT02088034 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT02088034?
The interventions under investigation include: Usual Care (OTHER), Promotora-led Intervention (BEHAVIORAL), Metformin Therapy (DRUG).
Who is sponsoring clinical trial NCT02088034?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02088034 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02088034's enrollment target sits among peer trials
92 200th of 338 higher than 138 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
RECRUITING · Phase 4
-
Efficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes
RECRUITING · Phase 4
-
Depression-Diabetes Mechanisms: Urban African Americans
COMPLETED · Phase 4
-
The Effects of Anti-Inflammatory Treatment on Insulin Resistance in Healthy Volunteers
COMPLETED · Phase 4
-
Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes
COMPLETED · Phase 4
-
Preventing Depression Recurrence in Diabetes
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia